hypertension
Conditions
Interventions
Management group:The management group will be provided with digital and intelligent lifestyle management guidance based on a digital health lifestyle management platform.
Conventional group:Routine lifestyle guidance
Sponsors
Fuwai Hospital, Chinese Academy of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1.Signed informed consent for the study, with priority given to patients not currently undergoing medication interventions; 2.Newly diagnosed hypertension; 3.Proficiency in using a smart communication device with Android 10 or higher; 4.Age = 18 years and = 50 years; 5.Clear consciousness, with the ability to understand and communicate with the researchers in writing or verbally, and able to cooperate in completing the study process; 6.Not participating in any drug clinical trials or other studies during the study period.
Exclusion criteria
Exclusion criteria: 1.Patients with acute myocardial infarction, acute rapid arrhythmia, pulmonary edema, severe aortic stenosis, and other severe circulatory and respiratory diseases; patients in the acute phase of cardiovascular and cerebrovascular diseases; patients with frequent premature beats and atrial fibrillation; patients with upper limb artery stenosis, carotid sinus syndrome; 2.Secondary or refractory hypertension patients; 3.Patients with cardiac pacemakers; allergy sufferers or women who are pregnant/planning to become pregnant; 4.Patients with fractures, joint instability, or other physical conditions preventing exercise; 5.Patients with skin diseases or injuries around the wearing area of the monitoring device; 6.Patients with psychiatric, epileptic or other disorders resulting in involuntary body movements or unable to cooperate; 7.Patients with BMI over 30 kg/m²; 8.Patients with limb deficiencies; 9.Patients with arm tremors or inability to maintain arm stability; 10.Patients deemed unsuitable for participation by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypertension control rate;Blood pressure level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Compliance with medication treatment for hypertension;Improvement in behavioral factors related to hypertension;Occurrence of major cardiovascular disease events;Occurrence of adverse events related to the study; | — |
Countries
China
Contacts
Public ContactWang Zengwu
Fuwai Hospital, Chinese Academy of Medical Science
Outcome results
None listed